Lung Cancer Trial, Recruiting NCT06756217 Sponsor: Ruijin Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06756217
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with primary non-small cell lung cancer (a specific type of lung cancer), confirmed by tissue testing.
  • People whose cancer is at a stage between IB and IIIA (using standard international staging guidelines) before any treatment has started.
  • People whose cancer has been specifically assessed by an experienced surgeon as being able to be surgically removed.
  • Men and women between 18 and 75 years of age.
  • People who are generally well enough to carry out light daily activities, as measured by a standard health scale (ECOG score of 0 or 1).
  • People whose life expectancy is estimated to be at least 6 months.
  • People who are willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

  • People whose tissue testing confirms a cancer type other than non-small cell lung cancer.
  • People whose lung cancer cannot be surgically removed, has spread to other parts of the body, or who are otherwise unable to undergo surgery for any reason.
  • People with a history of another cancer (with some exceptions, such as certain early-stage or skin cancers) unless that cancer has been fully cleared for at least 2 years before joining and no further treatment for it is needed during the trial period (confirm with trial site).
  • People with an active or past autoimmune disease, or a condition that required long-term use of steroid or immune-suppressing medications.
  • People with HIV, active hepatitis B, or hepatitis C infection.
  • People with diabetes that is not well controlled, or whose fasting blood sugar level is 11.0 mmol/L or higher on the day of testing.
  • Women who are pregnant, possibly pregnant, or currently breastfeeding.
  • People with a serious history of heart disease, severely reduced bone marrow function, or significant liver or kidney problems.
  • People who have previously received an organ transplant or a stem cell transplant from a donor.
  • People who, in the opinion of the trial team, have a medical, mental, or psychological condition that would prevent them from completing the trial or understanding the information provided about it.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 021-74370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
30 December 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Major Pathological Response (MPR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov